Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Bolsters Januvia Access With Outcomes-Based Discounts To CIGNA

Executive Summary

Merck will provide CIGNA with price discounts on Januvia and Janumet that are tied to member outcomes - lower blood sugar and medication adherence - in a novel contract arrangement announced by CIGNA April 23
Advertisement

Related Content

Payers’ Use Of Real-World Evidence For Drug Coverage On The Rise – IMS Health
Express Scripts Dispute With Walgreens Spotlights PBMs’ Thirst For Deeper Discounts
J&J Pushes New Treatment Paradigm for Invega Sustenna
J&J Pushes New Treatment Paradigm for Invega Sustenna
Novo Nordisk Makes Case For Alogliptin-Shadowed Victoza
Velcade Rebate Scheme In U.K. Sets Up Broader Cost-Effectiveness Review

Topics

Advertisement
UsernamePublicRestriction

Register

PS050993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel